TMAM
CERE

Tokio Marine Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Tokio Marine Asset Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-530,200
Closed -$21.7M – 572
2024
Q2 		$21.7M Buy
530,200
+142,400
+37% +$5.93M 1.04% 19
2024
Q1 		$16.4M Buy
+387,800
New +$16.3M 0.83% 28

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Tokio Marine Asset Management's CERE Position: Q3 2024 in Review

Tokio Marine Asset Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 530,200 shares — an estimated $21.7M sold.

Tokio Marine Asset Management first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $21.7M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Tokio Marine Asset Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Tokio Marine Asset Management sold 530,200 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $21.7M.
  • Tokio Marine Asset Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Tokio Marine Asset Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $21.7M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Tokio Marine Asset Management's 13F filing for Q3 2024, filed 6 Nov 2024.